Cognitive Functioning in Schizophrenia, Methamphetamine-induced Psychotic Disorder, and Healthy People: A Comparative Study

Document Type : Original Article


1 Department of Psychiatry, Shafa Psychiatry Hospital, Guilan University of Medical Sciences, Rasht, Iran

2 Department of Psychology, University of Guilan, Rasht, Iran

3 Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran


Background: Methamphetamine-induced psychotic disorder (MIP) cannot be easily differentiated from other psychotic disorders. Some studies have reported that patients with MIP and schizophrenia have differences in their cognitive functioning. We hypothesized that their performance would be different on neuropsychological tests which assess executive functions and visual memory. Materials and Methods: In a cross-sectional study, 30 patients with MIP, 31 patients with schizophrenia, and 31 healthy controls were assessed by Rey–Osterrieth complex figure (ROCF) test and visual search and attention test (VSAT). One-way analysis of variance was performed to compare the mean scores of tests. Tukey's HSD test was used for post hoc analysis. Results: Three groups had significant differences according to ROCF test (F = 15.76, P < 0.0001), VSAT (F = 39.78, P < 0.0001), left VSAT (F = 37.96, P < 0.0001), right VSAT (F = 40.40, P < 0.0001), and the time of the test administration (F = 3.26, P = 0.04). The post hoc analysis showed that the mean score of ROCF test and VSAT (total, right, and left) was significantly higher in the control group than in the other two groups. The time of administering the test in the control group was significantly shorter than in the MIP group (P < 0.03) and nonsignificantly shorter than in the schizophrenia group (P = 0.54). The mean score of right side VSAT was significantly higher in the MIP group than in the schizophrenia group. Conclusion: ROCF could not differentiate MIP from schizophrenia. The better performance of patients with MIP on right side VSAT that is reported in this and in the previous study needs to be reevaluated in more controlled studies.


Mokri A. Brief overview of the status of drug abuse in Iran. Arch Iran Med 2002;5:184-90.  Back to cited text no. 1
Mehrpour O. Methamphetamin abuse a new concern in Iran. Daru 2012;20:73.  Back to cited text no. 2
Shariatirad S, Maarefvand M, Ekhtiari H. Emergence of a methamphetamine crisis in Iran. Drug Alcohol Rev 2013;32:223-4.  Back to cited text no. 3
Lashkaripour K, Torbati E. Methamphetamine dependency. Int J High Risk Behav Addcict 2012;1:7-8.  Back to cited text no. 4
Zarrabi H, Khalkhali M, Hamidi A, Ahmadi R, Zavarmousavi M. Clinical features, course and treatment of methamphetamine-induced psychosis in psychiatric inpatients. BMC Psychiatry 2016;16:44.  Back to cited text no. 5
Riddle EL, Fleckenstein AE, Hanson GR. Mechanisms of methamphetamine-induced dopaminergic neurotoxicity. AAPS J 2006;8:E413-8.  Back to cited text no. 6
Kita T, Miyazaki I, Asanuma M, Takeshima M, Wagner GC. Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity. Int Rev Neurobiol 2009;88:43-64.  Back to cited text no. 7
Kita T, Takeshima M, Wagner GC, Hozumi H, Miyazaki I, Asanuma M. New perspectives on the mechanism of methamphetamine-induced neurotoxicity. Nihon Shinkei Seishin Yakurigaku Zasshi 2008;28:49-61.  Back to cited text no. 8
Panenka WJ, Procyshyn RM, Lecomte T, MacEwan GW, Flynn SW, Honer WG, et al. Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings. Drug Alcohol Depend 2013;129:167-79.  Back to cited text no. 9
McKetin R, Hickey K, Devlin K, Lawrence K. The risk of psychotic symptoms associated with recreational methamphetamine use. Drug Alcohol Rev 2010;29:358-63.  Back to cited text no. 10
Camacho A, Akiskal HS. Proposal for a bipolar-stimulant spectrum: Temperament, diagnostic validation and therapeutic outcomes with mood stabilizers. J Affect Disord 2005;85:217-30.  Back to cited text no. 11
Mahoney JJ 3rd, De La Garza R 2nd, Jackson BJ, Verrico CD, Ho A, Iqbal T, et al. The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders. Psychiatry Res 2014;219:367-71.  Back to cited text no. 12
Vosburgh HW, Mansergh G, Sullivan PS, Purcell DW. A review of the literature on event-level substance use and sexual risk behavior among men who have sex with men. AIDS Behav 2012;16:1394-410.  Back to cited text no. 13
Herbeck DM, Brecht ML. Substance use and mental health characteristics associated with cognitive functioning among adults who use methamphetamine. J Addict Dis 2013;32:11-25.  Back to cited text no. 14
McKetin R, Lubman DI, Najman JM, Dawe S, Butterworth P, Baker AL. Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study. Addiction 2014;109:798-806.  Back to cited text no. 15
Khalkhali SM, Najafi K, Ahmadi R, Yousefnezhad A, Hamidi A, Ellahi M, et al. Domestic violence in methamphetamine psychotic users, psychiatric inpatients, and healthy people: A comparative study. Iran J Med Sci 2016;41:486-93.  Back to cited text no. 16
Bramness JG, Gundersen ØH, Guterstam J, Rognli EB, Konstenius M, Løberg EM, et al. Amphetamine-induced psychosis – A separate diagnostic entity or primary psychosis triggered in the vulnerable? BMC Psychiatry 2012;12:221.  Back to cited text no. 17
Rusyniak DE. Neurologic manifestations of chronic methamphetamine abuse. Neurol Clin 2011;29:641-55.  Back to cited text no. 18
Kiyatkin EA. The hidden side of drug action: Brain temperature changes induced by neuroactive drugs. Psychopharmacology (Berl) 2013;225:765-80.  Back to cited text no. 19
Cadet JL, Krasnova IN. Molecular bases of methamphetamine-induced neurodegeneration. Int Rev Neurobiol 2009;88:101-19.  Back to cited text no. 20
Nordahl TE, Salo R, Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: A review. J Neuropsychiatry Clin Neurosci 2003;15:317-25.  Back to cited text no. 21
Grant KM, LeVan TD, Wells SM, Li M, Stoltenberg SF, Gendelman HE, et al. Methamphetamine-associated psychosis. J Neuroimmune Pharmacol 2012;7:113-39.  Back to cited text no. 22
Callaghan RC, Cunningham JK, Allebeck P, Arenovich T, Sajeev G, Remington G, et al. Methamphetamine use and schizophrenia: A population-based cohort study in California. Am J Psychiatry 2012;169:389-96.  Back to cited text no. 23
Srisurapanont M, Arunpongpaisal S, Wada K, Marsden J, Ali R, Kongsakon R, et al. Comparisons of methamphetamine psychotic and schizophrenic symptoms: A differential item functioning analysis. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:959-64.  Back to cited text no. 24
Orellana G, Slachevsky A. Executive functioning in schizophrenia. Front Psychiatry 2013;4:35.  Back to cited text no. 25
Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH, et al. Neurocognitive effects of methamphetamine: A critical review and meta-analysis. Neuropsychol Rev 2007;17:275-97.  Back to cited text no. 26
Hart CL, Marvin CB, Silver R, Smith EE. Is cognitive functioning impaired in methamphetamine users? A critical review. Neuropsychopharmacology 2012;37:586-608.  Back to cited text no. 27
van Holst RJ, Schilt T. Drug-related decrease in neuropsychological functions of abstinent drug users. Curr Drug Abuse Rev 2011;4:42-56.  Back to cited text no. 28
Nagai T, Yamada K. Molecular mechanism for methamphetamine-induced memory impairment. Nihon Arukoru Yakubutsu Igakkai Zasshi 2010;45:81-91.  Back to cited text no. 29
North A, Swant J, Salvatore MF, Gamble-George J, Prins P, Butler B, et al. Chronic methamphetamine exposure produces a delayed, long-lasting memory deficit. Synapse 2013;67:245-57.  Back to cited text no. 30
Chung A, Lyoo IK, Kim SJ, Hwang J, Bae SC, Sung YH, et al. Decreased frontal white-matter integrity in abstinent methamphetamine abusers. Int J Neuropsychopharmacol 2007;10:765-75.  Back to cited text no. 31
Weber E, Blackstone K, Iudicello JE, Morgan EE, Grant I, Moore DJ, et al. Neurocognitive deficits are associated with unemployment in chronic methamphetamine users. Drug Alcohol Depend 2012;125:146-53.  Back to cited text no. 32
Chen CK, Lin SK, Chen YC, Huang MC, Chen TT, Ree SC, et al. Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users. Drug Alcohol Depend 2015;148:158-64.  Back to cited text no. 33
Diamond A. Executive functions. Annu Rev Psychol 2013;64:135-68.  Back to cited text no. 34
Trenerry MR, Croosson B, Deboe J, Leber WR. Visual Search Attention Test. Odessa, Florida: Psychological Assessment Resources, Inc.; 1990.  Back to cited text no. 35
Filoteo JV, Williams BJ, Rilling LM, Roberts JV. Performance of Parkinson's disease patients on the visual search and attention test: Impairment in single-feature but not dual-feature visual search. Arch Clin Neuropsychol 1997;12:621-34.  Back to cited text no. 36
Jacobs E, Fujii D, Schiffman J, Bello I. An exploratory analysis of neurocognition in methamphetamine-induced psychotic disorder and paranoid schizophrenia. Cogn Behav Neurol 2008;21:98-103.  Back to cited text no. 37
Ezzatpanah Z, Shariat SV, Tehrani-Doost M. Cognitive functions in methamphetamine induced psychosis compared to schizophrenia and normal subjects. Iran J Psychiatry 2014;9:152-7.  Back to cited text no. 38
Bramness JG, Rognli EB. Psychosis induced by amphetamines. Curr Opin Psychiatry 2016;29:236-41.  Back to cited text no. 39
Salo R, Ursu S, Buonocore MH, Leamon MH, Carter C. Impaired prefrontal cortical function and disrupted adaptive cognitive control in methamphetamine abusers: A functional magnetic resonance imaging study. Biol Psychiatry 2009;65:706-9.  Back to cited text no. 40
Morgan EE, Woods SP, Poquette AJ, Vigil O, Heaton RK, Grant I. Visual memory in methamphetamine-dependent individuals: Deficient strategic control of encoding and retrieval. Aust N Z J Psychiatry 2012;46:141-52.  Back to cited text no. 41
Semkovska M, Bédard MA, Godbout L, Limoge F, Stip E. Assessment of executive dysfunction during activities of daily living in schizophrenia. Schizophr Res 2004;69:289-300.  Back to cited text no. 42
Mitrushina M, Boone K, Razani J, D'Elia L. Handbook of Normative Data for Neuropsychological Assessment. 2nd ed. USA:Oxford University Press; 2005. p. 241-53.  Back to cited text no. 43
Shin MS, Park SY, Park SR, Seol SH, Kwon JS. Clinical and empirical applications of the Rey-Osterrieth Complex Figure Test. Nat Protoc 2006;1:892-9.  Back to cited text no. 44
Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.  Back to cited text no. 45
Collins A, Koechlin E. Reasoning, learning, and creativity: Frontal lobe function and human decision-making. PLoS Biol 2012;10:e1001293.  Back to cited text no. 46
Lunt L, Bramham J, Morris RG, Bullock PR, Selway RP, Xenitidis K, et al. Prefrontal cortex dysfunction and ‘jumping to conclusions’: Bias or deficit? J Neuropsychol 2012;6:65-78.  Back to cited text no. 47
Rossi AF, Pessoa L, Desimone R, Ungerleider LG. The prefrontal cortex and the executive control of attention. Exp Brain Res 2009;192:489-97.  Back to cited text no. 48
Gazzaley A, Nobre AC. Top-down modulation: Bridging selective attention and working memory. Trends Cogn Sci 2012;16:129-35.  Back to cited text no. 49
Nobre AC, Stokes MG. Attention and short-term memory: Crossroads. Neuropsychologia 2011;49:1391-2.  Back to cited text no. 50
Elahipanah A, Christensen BK, Reingold EM. Visual selective attention among persons with schizophrenia: The distractor ratio effect. Schizophr Res 2008;105:61-7.  Back to cited text no. 51
Lu PH, Boone KB, Cozolino L, Mitchell C. Effectiveness of the Rey-Osterrieth Complex Figure Test and the Meyers and Meyers recognition trial in the detection of suspect effort. Clin Neuropsychol 2003;17:426-40.  Back to cited text no. 52
Göder R, Boigs M, Braun S, Friege L, Fritzer G, Aldenhoff JB, et al. Impairment of visuospatial memory is associated with decreased slow wave sleep in schizophrenia. J Psychiatr Res 2004;38:591-9.  Back to cited text no. 53
Behrmann M, Geng JJ, Shomstein S. Parietal cortex and attention. Curr Opin Neurobiol 2004;14:212-7.  Back to cited text no. 54
Halpin LE, Collins SA, Yamamoto BK. Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine. Life Sci 2014;97:37-44.  Back to cited text no. 55
Bernheim A, See RE, Reichel CM. Chronic methamphetamine self-administration disrupts cortical control of cognition. Neurosci Biobehav Rev 2016;69:36-48.  Back to cited text no. 56
Huang M, Huang Y, Yu L, Hu J, Chen J, Jin P, et al. Relationship between negative symptoms and neurocognitive functions in adolescent and adult patients with first-episode schizophrenia. BMC Psychiatry 2016;16:344.  Back to cited text no. 57
Hori H, Noguchi H, Hashimoto R, Nakabayashi T, Omori M, Takahashi S, et al. Antipsychotic medication and cognitive function in schizophrenia. Schizophr Res 2006;86:138-46.  Back to cited text no. 58